The National Academies of Sciences, Engineering and Medicine released a publication titled “Inclusion of Pregnant and Lactating Persons in Clinical Trials: Proceedings of a Workshop.” The National Academies Forum on Drug Discovery, Development, and Translation convened a workshop in June 2022 for stakeholders to examine the current state of evidence generation for drug products used by pregnant and lactating persons and to discuss barriers and opportunities for including these populations in clinical trials. This publication summarizes the presentations and discussions from the workshop.
NASEM Publication on Inclusion of Pregnant and Lactating Persons in Clinical Trials
